JPWO2022174094A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022174094A5 JPWO2022174094A5 JP2023548552A JP2023548552A JPWO2022174094A5 JP WO2022174094 A5 JPWO2022174094 A5 JP WO2022174094A5 JP 2023548552 A JP2023548552 A JP 2023548552A JP 2023548552 A JP2023548552 A JP 2023548552A JP WO2022174094 A5 JPWO2022174094 A5 JP WO2022174094A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- copper
- delivery
- eye
- myopia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000001491 myopia Diseases 0.000 claims description 8
- 230000004379 myopia Effects 0.000 claims description 8
- 210000004087 cornea Anatomy 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 37
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 229910052802 copper Inorganic materials 0.000 claims 6
- 239000010949 copper Substances 0.000 claims 6
- YRNNKGFMTBWUGL-UHFFFAOYSA-L copper(ii) perchlorate Chemical compound [Cu+2].[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O YRNNKGFMTBWUGL-UHFFFAOYSA-L 0.000 claims 3
- HXUMOVKKXUVBRH-UHFFFAOYSA-L copper diperbromate Chemical compound Br(=O)(=O)(=O)[O-].[Cu+2].Br(=O)(=O)(=O)[O-] HXUMOVKKXUVBRH-UHFFFAOYSA-L 0.000 claims 2
- KAGCXMYEBHGUDI-UHFFFAOYSA-L copper;diperiodate Chemical compound [Cu+2].[O-]I(=O)(=O)=O.[O-]I(=O)(=O)=O KAGCXMYEBHGUDI-UHFFFAOYSA-L 0.000 claims 2
- 208000001309 degenerative myopia Diseases 0.000 claims 2
- 230000004515 progressive myopia Effects 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 210000000795 conjunctiva Anatomy 0.000 claims 1
- 210000003717 douglas' pouch Anatomy 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000003002 pH adjusting agent Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 210000003786 sclera Anatomy 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 230000002459 sustained effect Effects 0.000 claims 1
- 210000001760 tenon capsule Anatomy 0.000 claims 1
- 239000010409 thin film Substances 0.000 claims 1
- 239000012929 tonicity agent Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 201000004569 Blindness Diseases 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 208000010415 Low Vision Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163148344P | 2021-02-11 | 2021-02-11 | |
| US63/148,344 | 2021-02-11 | ||
| PCT/US2022/016205 WO2022174094A1 (en) | 2021-02-11 | 2022-02-11 | Treatment of myopia |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024508706A JP2024508706A (ja) | 2024-02-28 |
| JPWO2022174094A5 true JPWO2022174094A5 (https=) | 2025-02-20 |
| JP2024508706A5 JP2024508706A5 (https=) | 2025-02-20 |
Family
ID=82837328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548552A Pending JP2024508706A (ja) | 2021-02-11 | 2022-02-11 | 近視の治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240122974A1 (https=) |
| EP (1) | EP4291163A4 (https=) |
| JP (1) | JP2024508706A (https=) |
| KR (1) | KR20240021734A (https=) |
| CN (1) | CN118234482A (https=) |
| AU (1) | AU2022220331A1 (https=) |
| CA (1) | CA3208185A1 (https=) |
| TW (1) | TW202302121A (https=) |
| WO (1) | WO2022174094A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250109788A (ko) * | 2018-01-05 | 2025-07-17 | 유니버시티 오브 유타 리서치 파운데이션 | 근시 진행의 치료 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040058015A1 (en) * | 2000-06-01 | 2004-03-25 | Yuanjin Tao | Compositions and methods for treating eye discomfort and eye disease |
| US20040001791A1 (en) * | 2000-11-16 | 2004-01-01 | Zeiler Kenneth T. | Composition, method of use, and devices for the treatment of onychomycosis |
| US9504603B2 (en) * | 2012-04-02 | 2016-11-29 | Ocuject, Llc | Intraocular delivery devices and methods therefor |
| JP6898734B2 (ja) * | 2013-10-07 | 2021-07-07 | オクジェクト, リミテッド ライアビリティー カンパニーOcuject, Llc | 針アセンブリ |
| US11065275B2 (en) * | 2016-03-08 | 2021-07-20 | University Of Utah Research Foundation | Cross-linking agents and associated methods |
| KR20250109788A (ko) * | 2018-01-05 | 2025-07-17 | 유니버시티 오브 유타 리서치 파운데이션 | 근시 진행의 치료 |
| CN109776623B (zh) * | 2019-03-05 | 2021-05-07 | 潍坊科技学院 | 一种含氟草酰胺同/异核化合物的制备方法与应用 |
-
2022
- 2022-02-10 TW TW111104966A patent/TW202302121A/zh unknown
- 2022-02-11 AU AU2022220331A patent/AU2022220331A1/en active Pending
- 2022-02-11 CN CN202280027799.6A patent/CN118234482A/zh active Pending
- 2022-02-11 WO PCT/US2022/016205 patent/WO2022174094A1/en not_active Ceased
- 2022-02-11 CA CA3208185A patent/CA3208185A1/en active Pending
- 2022-02-11 JP JP2023548552A patent/JP2024508706A/ja active Pending
- 2022-02-11 KR KR1020237030954A patent/KR20240021734A/ko active Pending
- 2022-02-11 US US18/546,258 patent/US20240122974A1/en active Pending
- 2022-02-11 EP EP22753451.8A patent/EP4291163A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2806942C (en) | Compounds for the treatment/prevention of ocular inflammatory diseases | |
| US20040137068A1 (en) | Ophthalmic formulation for the prevention and treatment of adverse ocular conditions, particularly those associated with the aging eye | |
| JP2021509902A5 (https=) | ||
| JP2019524826A5 (https=) | ||
| US20060172972A1 (en) | Formulation and method for administration of ophthalmologically active agents | |
| WO2010004435A2 (en) | Formulations for treating eye disorders | |
| JP7795555B2 (ja) | 近視を治療するための方法及び薬物組成物 | |
| AU2020290443A1 (en) | Carabachol-bromonidine formulation to enhance anti-presbyopia effects | |
| AU2020290998A1 (en) | Using parasympathomimetic drugs alone or, in combination with one or more alpha agonists in pseudophakic patients, to create multi-focality | |
| JPWO2020074697A5 (https=) | ||
| CN118384160A (zh) | 用于控制和/或降低近视发展的药物组合物 | |
| Macsai et al. | Keratoconus and Turner's syndrome | |
| Bagnis et al. | Antiglaucoma drugs: The role of preservative-free formulations | |
| JP2021534217A5 (https=) | ||
| JPWO2022174094A5 (https=) | ||
| US20210085696A1 (en) | Formulations comprising chelators, permeation enhancers and hydroxyethyl cellulose for treating ophthalmic disorders | |
| Alwitry et al. | Severe decompression retinopathy after medical treatment of acute primary angle closure | |
| WO2002080915A2 (en) | Composition for the treatment of night sight problems (halos, coma and glare) comprising aceclidine | |
| Fourman | Acute closed-angle glaucoma after arteriovenous fistulas | |
| JPWO2019136358A5 (https=) | ||
| HURWITZ et al. | Uses of naphazoline (privine®) in ophthalmology | |
| JPWO2020041340A5 (https=) | ||
| Snyder et al. | Hypopyon iridocyclitis associated with extended-wear soft contact lenses | |
| JP2023022567A (ja) | 洗眼組成物 | |
| Benson et al. | Vitrectomy for a persisting macular fold in a case of resolved hypotony maculopathy |